We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
In 2023, West turned 100. As I look back across the year, I am proud to be part of this amazing organization. Our 100th year in service was a time to reflect on our heritage, celebrate everything we have achieved and look forward to our future with a renewed sense of determination.
West is a global market leader of innovative, high-quality injectable drug packaging and delivery systems supporting the therapeutic and vaccine needs of global pharmaceutical and biotechnology companies.
If you have ever been vaccinated, or if you or a loved one has ever needed to take an injected medicine, the injectable drug mostly likely was contained or delivered with a West product.
Our founder, Herman O. West, had a vision to innovate new solutions that would improve patients’ lives around the world. His principles of ‘never standing still’ and ‘always doing good’ have remained steadfast since our very beginnings.
Still to this day, our philosophy remains grounded in the important role we play in delivering life-saving medicines and the knowledge that every component we produce has a patient’s name on it.
Today we are 10,000 team members working together across 50 sites worldwide, to deliver over 47 billion components and devices each year. That’s over 128 million products every day… trusted by our customers… making a difference to patients. And throughout this year, we continued to expand our manufacturing capabilities so that we can continue to meet our customers’ needs into the future.
In our 100th year we worked hard to fulfill our purpose of improving patients’ lives around the world. And we also celebrated reaching this incredible milestone with a network of our local champions, all around the world – Team 100. They masterminded local anniversary celebrations at each of our global locations. It has been inspiring to see our team members coming together, having fun, building bonds and creating memories.
Sustainability and corporate responsibility remain a continued focus for West. We have continued to give back to the communities we serve. Collecting more than 751,000 meals during our annual food drive and raising $340,000 during our West without Borders* Campaign, our employee-led giving program. We were excited to have partnered with the Philadelphia Eagles on our Field Goal Forest initiative and collaborate with Corning® for sustainable drug delivery with the launch of Viridian™ vials.
The past few years have been a reminder that the world doesn’t stand still. And the needs of the healthcare industry are evolving and growing in complexity, from novel molecules and therapies to the increasing expectations of patients to shift treatment options from the hospital to the home setting.
West remains committed to the pursuit of scientific innovation and partnerships to address the changing needs of today and the next 100 years. Earlier this year we opened a state-of-the-art R&D Lab in Radnor, Pennsylvania supporting enhancements in chemistry, materials sciences and biology. This facility will allow us to bring our scientific and technical expertise together, so we can continue to define what’s possible in improving patients’ health.
I have immense pride for all that our One West Team has achieved in 2023 and honored to have had the opportunity to celebrate our 100 years in business together. May the holiday season bring you peace and joy, and a happy new year ahead.
*West without Borders is not affiliated with Doctors Without Borders®, which is a registered service mark of Bureau International de Médecins San Frontières.
Fran DeGrazio, Vice President, Global R&D, TCS and SPM, Pharmaceutical Packaging Systems, recently contributed a chapter on primary container components to <em>Quality by Design for Biopharmaceutical Drug Product Development</em>. The volume, which was released in April 2015, is the first comprehensive overview of QbD as it applies to nearly every aspect of biopharmaceutical development.
Imagine self-administered cancer treatments in the comfort of a patient’s home. How close are we to making this a reality? During this unprecedented time, immuno-compromised patients can benefit from receiving a self-administered, home-based treatment option. One major factor into making home-based cancer treatment a reality is a focus on shifting the route of administration from intravenous to subcutaneous delivery. Due to an emphasis on patient involvement in shared decision making for health care policy and medical approaches, understanding the intravenous to subcutaneous transition in medical injections has garnered increased importance. If therapeutic efficacy is not compromised, the less invasive nature and convenience of subcutaneous injections is often the preferred route of administration.<sup>1-2,4-6</sup>
Did you miss the free West 2013 Educational Series? Join us in 2014!
When evaluating the vial system for your drug product, how do you know you’re making good decisions about protecting the drug product while also meeting regulatory expectations for data requirements as outlined in ICH Q9? To illustrate how complex it is to determine how much data is enough to make good, sound, decisions on your vial containment system, two 20mm container closure systems (CCS) were evaluated with the primary difference being the hardness of the rubber vial stopper. The designs were identical for each stopper, meaning the specifications, nominal dimensions, and other major features were the same.
<em>The West Ambassador Internship Program is a 10-week program that provides college students with meaningful, practical, real-word experience and the opportunity to learn from and work alongside industry experts.</em>
English
Chinese
